Differentiation HHD From HCM (EARLY-MYO-HHD)

CompletedOBSERVATIONAL
Enrollment

465

Participants

Timeline

Start Date

July 1, 2017

Primary Completion Date

December 31, 2021

Study Completion Date

December 31, 2021

Conditions
Hypertrophic CardiomyopathyHypertensive Heart Disease
Interventions
DIAGNOSTIC_TEST

evaluated by the predetermined differentiating formula

After recruiting patients, collecting the baseline data, a CMR scan will be carried out and post-processed, a predetermined differentiating formula (including left ventricular morphology, ejection fraction, presence of late gadolinium enhancement, T1 value and strain data) will be used to produce a cardiac values, which is to be input into our differentiating flow.

Trial Locations (1)

200127

Renji Hospital, Shanghai

All Listed Sponsors
collaborator

Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University

OTHER

collaborator

Ruijin Hospital

OTHER

collaborator

LanZhou University

OTHER

collaborator

Kunming Medical University

OTHER

collaborator

Beijing Anzhen Hospital

OTHER

collaborator

West China Hospital

OTHER

lead

RenJi Hospital

OTHER

NCT03271385 - Differentiation HHD From HCM (EARLY-MYO-HHD) | Biotech Hunter | Biotech Hunter